The effect of risankizumab on achieving minimal clinically important differences in patient‐reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2

por Kristensen, L.E., Soliman, A.M., Papp, K., Barcomb, L., Eldred, A., Östör, A.
Publicado 2022

Hypovitaminosis D among rheumatology outpatients in clinical practice

por Mouyis, M., Ostor, A. J. K., Crisp, A. J., Ginawi, A., Halsall, D. J., Shenker, N., Poole, K. E. S.
Publicado 2008

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, co...

por Emery, P, Gottenberg, J E, Rubbert-Roth, A, Sarzi-Puttini, P, Choquette, D, Taboada, V M Martínez, Barile-Fabris, L, Moots, R J, Ostor, A, Andrianakos, A, Gemmen, E, Mpofu, C, Chung, C, Gylvin, L Hinsch, Finckh, A
Publicado 2015